Why Do We Need Another Kidney Function Biomarker? The Case for Clinical Adoption of Cystatin C

This event has passed and can no longer be viewed

This event was presented live or live-streamed and has not been designated for on-demand presentation.

This Michael E. DeBakey VAMC Grand Rounds session will take place on Friday, August 20, 2021 at 12:15 P.M. Live attendance for this session will only be available through Zoom.

Activity Information

Needs Statement

Internal Medicine generalists and subspecialists, residents, fellows, medical and physician assistant students who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in internal medicine and medical ethics to increase clinical knowledge and to implement them in clinical practice to enhance the quality of patient care and outcomes.

Educational Objectives

At the conclusion of the session, the participants should be able to:

  • Analyze the advantages and disadvantages of serum creatinine and cystatin C in kidney disease detection.
  • Demonstrate greater understanding of the epidemiological evidence supporting cystatin C as a biomarker of kidney function.
  • Identify the clinical utility of cystatin C in real-world practice.

Target Audience

Professional Categories

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Other Health Professionals

Specialties

  • Internal Medicine

Interest Groups

  • Hospital Medicine

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Director

  1. Prathit Kulkarni, M.D., FACP

    Prathit Kulkarni, M.D., FACP

    Assistant Professor, Assistant Chief of Medicine, Associate Program Director of the Infectious Disease Fellowship
    Baylor College of Medicine, Michael E. DeBakey VA Medical Center

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Michelle M. Estrella, M.D., M.H.S.

    Michelle M. Estrella, M.D., M.H.S.

    Chief, Renal Section at the San Francisco VA Health Care System
    University of California –San Francisco

    Disclosure:
    • Research Support: Bayer, Inc.
    • Consultancy: AstraZeneca; Boehringer-Ingelheim

Activity Director

  1. Prathit Kulkarni, M.D., FACP

    Prathit Kulkarni, M.D., FACP

    Assistant Professor, Assistant Chief of Medicine, Associate Program Director of the Infectious Disease Fellowship
    Baylor College of Medicine, Michael E. DeBakey VA Medical Center

    Disclosure:
    • Research Support: Vessel Health, Inc.

Planning Committee Members

  1. Jeffrey Bates, M.D.

    Jeffrey Bates, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Stephen Bujarski, M.D.

    Stephen Bujarski, M.D.


    Disclosure:

    Nothing to disclose.

  3. Andrew Caruso, M.D.

    Andrew Caruso, M.D.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  4. Prathit Kulkarni, M.D., FACP

    Prathit Kulkarni, M.D., FACP

    Assistant Professor, Assistant Chief of Medicine, Associate Program Director of the Infectious Disease Fellowship
    Baylor College of Medicine, Michael E. DeBakey VA Medical Center

    Disclosure:
    • Research Support: Vessel Health, Inc.
  5. Cory Ritter, M.D.

    Cory Ritter, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  6. Maulin Shah, M.D.

    Maulin Shah, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  7. Supriya Singh, M.D.

    Supriya Singh, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  8. Madhuri M. Vasudevan, M.D., M.P.H.

    Madhuri M. Vasudevan, M.D., M.P.H.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Presenter:

Michelle M. Estrella, M.D., M.H.S.

Michelle M. Estrella, M.D., M.H.S.

Chief, Renal Section at the San Francisco VA Health Care System University of California –San Francisco

Health Topics

You May Also Be Interested In

On Demand
Department of Medicine Grand Rounds
Activity duration: 1 hr 15 min
Activity Available On Demand
Credit No credit is available for this activity
Upcoming
Gynecologic Oncology Tumor Board
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available
Upcoming
Gynecologic Oncology Tumor Board
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available